Influence of Amerindian mitochondrial DNA haplogroups on thrombosis susceptibility and frequency of four genetic prothrombotic variants in Southern Chilean subjects

Clinica Chimica Acta

Volumn 411, Issue 5-6, 2010, Pages 444-447

  Guzmán, Neftalí ^a,b,c   Lanas, Fernando ^a,b   Salazar, Luis A ^a,b  

^a UNIVERSIDAD DE LA FRONTERA   (Chile)

^b UNIVERSIDAD DE LA FRONTERA   (Chile)

^c UNIVERSIDAD SAN SEBASTIÁN   (Chile)

Author keywords

Amerindian population; Deep venous thrombosis; mtDNA haplogroups; MTHFR 677C > T polymorphism; Risk factors

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5; MITOCHONDRIAL DNA; PROTHROMBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE PREDISPOSITION; DNA POLYMORPHISM; DOPPLER ECHOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOPHILIA; VEIN THROMBOSIS;

EID: 75049084337     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.01.007     Document Type: Article

References (40)

1. Fowkes F.J., Price J.F., and Fowkes G. Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg 25 (2004) 1-5
2. Anderson F., and Spencer F. Risk factors for venous thromboembolism. Circulation 107 (2003) I9-I16
3. Angchaisuksiri P., Pingsuthiwong S., Aryuchai K., et al. Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population. Am J Hematol 65 (2000) 119-122
4. Bauduer F., and Lacombe D. Factor V Leiden, prothrombin 20210A, methylenetetrahydrofolate reductase 677 T, and population genetics. Mol Genet Metabol 86 (2005) 91-99
5. Lu Y., Zhao Y., Liu G., et al. Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population. Thromb Res 106 (2002) 7-12
6. Chinnery P., Mowbray C., Pate S., et al. Mitochondrial DNA haplogroups and type 2 diabetes: a study of 897 cases and 1010 controls. J Med Genet 44 (2007) e80
7. Rosa A., Fonseca B., Krug T., et al. Mitochondrial haplogroup H1 is protective for ischemic stroke in Portuguese patients. BMC Med Genet 9 (2008) 57-67
8. Benn M., Schwartz M., Nordestgaard B., and Tybjærg-Hansen A. Mitochondrial haplogroups: ischemic cardiovascular disease, other diseases, mortality, and longevity in the general population. Circulation 117 (2008) 2492-2501
9. Vigilant I., Stoneking M., Harpending H., Hawkes K., and Wilson A. African populations and the evolution of human mitochondrial DNA. Science 253 (1991) 1503-1507
10. Di Renzo A., and Wilson A. Branching pattern in the evolutionary tree for human mitochondrial DNA. PNAS 88 (1991) 1597-1601
11. Bailliet G., Rothhamer F., Carnese F., Bravi C., and Bianchi N. Founder mitochondrial haplogroups in Amerindian populations. Am J Hum Genet 50 (1994) 592-601
12. Santos S., Ribeiro-Dos Santos A., Meyer D., and Zago M. Multipler founder haplotypes of mitochondrial DNA Amerindians revealed by RFLP and sequency. Ann Hum Genet 60 (1996) 305-319
13. Fuselli S., Tarazona-Santos E., Dupanloup I., Soto A., Luiselli D., and Pettener D. Mitochondrial DNA diversity in South America and the genetic history of Andean Highlanders. Mol Biol Evol 20 (2003) 1682-1691
14. Moraga M., Rocco P., Miquel J., et al. Mitochondrial DNA polymorphisms in Chilean aboriginal populations: implications for the peopling of the southern cone of the continent. Am J Phys Anthropol 113 (2000) 19-29
15. Rocco P., Morales C., Moraga M., et al. Composición genética de la población chilena: Distribución de polimorfismos de DNA mitocondrial en grupos originarios y en la población mixta de Santiago. Rev Med Chile 130 (2002) 125-131
16. García F., Moraga M., Vera S., et al. mtDNA microevolution in Southern Chile's archipelagos. Am J Phys Anthropol 129 (2006) 473-481
17. Salazar L.A., Hirata M., Cavalli S., et al. Optimized procedure DNA isolation from fresh and cryopreserved clotted human blood useful in clinical molecular testing. Clin Chem 44 8 (1998) 1748-1750
18. Bertina R.M., Koeleman B.P.C., Koster T., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369 (1994) 64-67
19. Poort S.R., Rosendaal F.R., Reitsma P.H., and Bertina R.M. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88 10 (1996) 3698-3703
20. Frosst P., Blom H., Milos R., et al. A candidate genetic risk factor for vascular diseases: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 10 (1995) 111-113
21. Blake G., Schmitz C., Lindpaintner K., and Ridker P. Mutation in the promotor region of the β-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis. Eur Heart J 22 (2001) 2262-2266
22. Bonatto S., and Salzano F. A single early migration for the peopling of the Americas supported by mitochondrial DNA sequence data. PNAS 94 (1997) 1866-1871
23. Castro M.G., Huerta C., Reguero J.R., et al. Mitochondrial DNA haplogroups in Spanish patients with hypertrophic cardiomyopathy. Int J Cardiol 112 (2006) 202-206
24. Nishigaki Y., Yamada Y., Fuku N., et al. Mitochondrial haplogroup N9b is protective against myocardial infarction in Japanese males. Hum Genet 120 (2007) 827-836
25. Zivelin A., Griffin J., Xu X., et al. A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood 89 (1997) 397-402
26. Zivelin A., Mor-Cohen R., Kovalsky V., et al. Prothrombin 20210G>A is an ancestral prothrombotic mutation that occurred in whites approximately 24 000 years ago. Blood 107 (2006) 4666-4668
27. Rodrigues C., Rocha L., Morelli V., Franco R., and Lourenco D. Prothrombin G20210A mutation, and not factor V Leiden mutation, is a risk factor for cerebral venous thrombosis in Brazilian patients. J Thromb Haemost 2 (2004) 1211-1212
28. Genoud V., Castañon M., Annichino-Bizzacchi J., Korin J., and Kordich L. Prevalence of three prothrombotic polymorphisms: factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase (MTHFR) C677T in Argentina. Thromb Res 100 (2000) 127-131
29. Corach D., Marino M., and Sala A. Relevant genetic contribution of Amerindian to the extant population of Argentina. Int Congress Series 1288 (2006) 397-399
30. Pereira J., Quiroga T., Goycoolea M., et al. Resistencia a la Proteína C Activada: Estudio de laboratorio y prevalencia del defecto in población chilena. Rev Med Chile 124 (1996) 663-668
31. Palomo I., Pereira J., Alarcón M., et al. Factor V Leiden y mutación de la protrombina G20210A en pacientes con trombosis venosa y arterial. Rev Med Chile 133 (2005) 1425-1433
32. Rocco P., Morales C., Moraga M., et al. Composición genética de la población chilena. Distribución de polimorfismos de DNA mitocondrial en grupos originarios y en la población mixta de Santiago. Rev Med Chile 130 (2002) 125-131
33. Arruda V., Siqueira L., Gonçalves M., et al. Prevalence of the mutation C677 > T in the Methylenetetrahydrofolate reductase gene among distinct ethnic groups in Brazil. Am J Med Genet 78 (1998) 332-335
34. Camacho O., Giusti B., Restrepo Fernandez C.M., Abbate R., and Pepe G. Frequency of factor V (FV) Leiden and C677T Methylenetetrahydrofolate reductase (MTHFR) mutation in Colombians. Thromb Haemost 79 (1998) 883-884
35. Pepe G., Camacho V., Giusti T., et al. Heterogeneity in world distribution of the thermolabile C677T mutation in 5, 10-methylenetetrahydrofolate reductase. Am J Hum Genet 63 (1998) 917-920
36. Mukherjee M., Joshi S., Bagadi S., Dalvi M., Rao A., and Shetty K.R. A low prevalence of the C677T mutation in the methylenetetrahydrofolate reductase gene in Asian Indians. Clin Genet 61 (2002) 155-159
37. Herrmann F.H., Koesling M., Schroder W., et al. Prevalence of factor V Leiden mutation in various populations. Genet Epidemiol 14 (1997) 403-411
38. Den Heijer M., Lewington S., and Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 3 (2005) 292-299
39. Dowling N., Austin H., Dilley A., Wiitsett C., Evatt B.L., and Hooper W.C. The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE study. J Thromb Haemost 1 (2003) 80-87
40. Tsai A.W., Cushman M., Tsai M.Y., et al. Serum homocysteine, thermolabile variant of metylenetetrahydrofolate reductase (MTHFR), and venous thromboembolism: longitudinal investigation of thromboembolism (LITE). Am J Hematol 72 (2003) 192-200